LSA
NVAX icon

Leonteq Securities AG’s Novavax NVAX Stock Holding History

Leonteq Securities AG’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Sell
16,464
-5,351
-25% -$47.9K 0.01% 620
2026
Q1 		$178K Sell
21,815
-10,504
-33% -$95.2K 0.01% 626
2025
Q4 		$217K Buy
32,319
+1,322
+4% +$9.97K 0.01% 650
2025
Q3 		$269K Sell
30,997
-22,381
-42% -$174K 0.01% 543
2025
Q2 		$336K Sell
53,378
-22,721
-30% -$150K 0.01% 459
2025
Q1 		$489K Buy
76,099
+8,757
+13% +$72.4K 0.03% 366
2024
Q4 		$541K Buy
67,342
+25,726
+62% +$248K 0.04% 335
2024
Q3 		$526K Buy
41,616
+5,481
+15% +$70.8K 0.04% 317
2024
Q2 		$457K Sell
36,135
-181,131
-83% -$1.82M 0.03% 321
2024
Q1 		$1.04M Buy
217,266
+11,280
+5% +$52.3K 0.08% 222
2023
Q4 		$989K Buy
205,986
+99,482
+93% +$609K 0.06% 251
2023
Q3 		$771K Buy
106,504
+45,696
+75% +$365K 0.04% 294
2023
Q2 		$452K Sell
60,808
-22,828
-27% -$180K 0.02% 409
2023
Q1 		$580K Buy
83,636
+750
+0.9% +$6.9K 0.03% 348
2022
Q4 		$852K Sell
82,886
-8,436
-9% -$149K 0.03% 305
2022
Q3 		$1.66M Buy
91,322
+2,894
+3% +$125K 0.06% 207
2022
Q2 		$4.55M Sell
88,428
-39,259
-31% -$2.03M 0.17% 116
2022
Q1 		$9.4M Buy
127,687
+44,484
+53% +$3.97M 0.34% 63
2021
Q4 		$11.9M Buy
83,203
+61,770
+288% +$10.6M 0.43% 48
2021
Q3 		$4.44M Buy
21,433
+11,740
+121% +$2.59M 0.19% 103
2021
Q2 		$2.06M Buy
9,693
+7,010
+261% +$1.28M 0.12% 154
2021
Q1 		$486K Sell
2,683
-1,542
-36% -$307K 0.03% 392
2020
Q4 		$471K Buy
+4,225
New +$449K 0.03% 408

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Leonteq Securities AG's NVAX Position: Q2 2026 in Review

Leonteq Securities AG reduced its Novavax (NVAX) stake by 25% in Q2 2026, selling an estimated $47.9K and leaving 16,464 shares worth $155K. The position accounts for 0.01% of the portfolio, ranked #620.

Leonteq Securities AG first reported a position in NVAX in Q4 2020 and has held it in 23 quarters since. The position peaked at $11.9M in Q4 2021. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Leonteq Securities AG held 16,464 shares of Novavax worth $155K as of Q2 2026.
  • Leonteq Securities AG sold 5,351 Novavax shares in Q2 2026, an estimated $47.9K.
  • Novavax made up 0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #620 holding.
  • Leonteq Securities AG first reported a position in Novavax in Q4 2020 and has held it in 23 quarters since.
  • Leonteq Securities AG's Novavax position peaked at $11.9M in Q4 2021.
  • 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.